Physician

Scott C Carrizales, MD

According to 2025 Medicare claims, Scott Carrizales, MD (NPI: 1063443588) practices dermatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Clair, IL. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1427589027; TIN: 391351587) and primary practice location at 62269-1848.

Carrizales' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 370 traditional Medicare patients, billed 7,739 HCPCS/CPT codes, and received $330,433 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 686 prescription claims across 247 beneficiaries totaling $129,044 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 27 records totaling $464. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $46,214 to $330,433. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $39,001 and ending at $129,044. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	149	909	$46,214
2016	245	1,606	$81,444
2017	393	2,603	$96,865
2018	390	6,961	$114,540
2019	432	3,577	$100,305
2020	280	1,723	$73,580
2021	290	5,168	$193,840
2022	336	5,534	$400,186
2023	405	7,664	$519,965
2024	370	7,739	$330,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	84	187	$39,001
2016	146	409	$136,690
2017	203	551	$207,738
2018	213	646	$231,496
2019	277	731	$251,963
2020	162	412	$31,720
2021	157	467	$21,037
2022	172	491	$60,094
2023	217	649	$78,973
2024	247	686	$129,044

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17004	Destruction of precancer skin growth, 15 or more growths	98	137	$116
11102	Biopsy of related skin growth, first growth	163	191	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	286	519	$62
17000	Destruction of precancer skin growth, 1 growth	231	348	$41
17003	Destruction of precancer skin growth, 2-14 growths	206	1,933	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clobetasol Propionate	Clobetasol Propionate	130	3,907	$7,041
Triamcinolone Acetonide	Triamcinolone Acetonide	194	5,874	$2,943
Metronidazole	Metronidazole	14	530	$1,644
Tacrolimus	Tacrolimus	13	350	$1,392
Mometasone Furoate	Mometasone Furoate	53	1,590	$1,271

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$464	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott C. Carrizales, MD?

Tedicare shows public-source Medicare data for Scott C. Carrizales, MD (NPI 1063443588), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott C. Carrizales, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott C. Carrizales, MD?

Scott C. Carrizales, MD is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1427589027) in the available physician profile data.

Does Scott C. Carrizales, MD have Open Payments data?

Scott C. Carrizales, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.